<DOC>
	<DOCNO>NCT00630825</DOCNO>
	<brief_summary>To study weekly injection LY2189265 compare placebo blood glucose measure glycosylated hemoglobin ( HbA1c ) change baseline 16 week overweight Type 2 Diabetes Mellitus participant .</brief_summary>
	<brief_title>A Study Dose Titration LY2189265 Overweight Participants With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Dulaglutide</mesh_term>
	<criteria>Type 2 Diabetes Mellitus &gt; 3 month history prior enter trial , base disease diagnostic criterion American Diabetes Association ( ADA 2007 ) . Men woman 18 year age old . Women must negative pregnancy test willing use birth control study duration one month post . Have glycosylated hemoglobin ( HbA1c ) &gt; 7.0 % ≤10.5 % determined central laboratory screening . Have body mass index ( BMI ) 27 40 kilograms/meter square ( kg/m^2 ) , inclusive . Have dos 3 month approve combination 2 oral antihyperglycemic medication combination follow : sulfonylurea ( e.g . Chlorpropamide Diabinese , Glimepiride Amaryl , Tolbutamide Orinase , Tolazamide Tolinase , Glipizide Glucotrol , Glyburide also know Micronase , Diabeta , Glynase ) , biguanides ( e.g . Glucophage metformin ) , thiazolidinediones ( e.g . Rosiglitazone Avandia , Pioglitazone Actos ) , dipeptidyl peptidase 4 ( DPPIV ) inhibitor ( e.g . Sitagliptin Januvia ) . A combination pill 2 drug allow ( 1 ) , ( e.g . Metformin Glipizide Metaglip ) , ( e.g . Metformin Glyburide Glucovance ) , ( e.g . Pioglitazone Glimepiride Duetact ) , ( e.g . Sitagliptin Metformin Janumet ) . Have know Type 1 Diabetes Mellitus Have take glucagonlike peptide1 ( GLP1 ) GLP1 analog drug ( Byetta ) Have history unstable angina , heart attack ( myocardial infarction ) , heart arrhythmia ( ventricular ) , congestive heart failure , coronary intervention ( percutaneous transluminal coronary angioplasty [ PTCA ] , open heart surgery , coronary artery bypass graft [ CABG ] ) , transient ischemic attack ( TIA ) stroke ( cerebrovascular accident ) last 6 month prior screen . Have acute chronic hepatitis elevate liver function test ( alanine transaminase ) , history chronic recurrent pancreatitis . Have renal disease serum creatinine ( blood test ) &gt; 2 milligram per deciliter ( mg/dL ) . If take biguanides ( e.g . metformin Glucophage ) , DPPIV inhibitor ( e.g . Sitagliptin Januvia Janumet ) , creatinine must ≤1.5 mg/dL . Currently take prescription counter medication prevent weight loss .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>